Manganese

What is Manganese

Manganese is naturally ubiquitous in the environment, it can be found in rocks and soil and in trace amounts is essential for good health. Manganese is essential for normal physiologic functioning in humans and animals, and exposure to low levels of manganese in the diet is considered to be nutritionally essential in humans and at the same time it can also be potentially toxic ¹, ². Manganese is a component of some enzymes and stimulates the development and activity of other enzymes ³. Manganese superoxide dismutase (MnSOD) is the principal antioxidant in mitochondria. Several enzymes activated by manganese contribute to the metabolism of carbohydrates, amino acids, and cholesterol ⁴).

Chronic (long-term) exposure to high levels of manganese by inhalation in humans may result in central nervous system effects. Visual reaction time, hand steadiness, and eye-hand coordination were affected in chronically-exposed workers. A syndrome named manganism may result from chronic exposure to higher levels; manganism is characterized by feelings of weakness and lethargy, tremors, a mask-like face, and psychological disturbances. Respiratory effects have also been noted in workers chronically exposed by inhalation. Impotence and loss of libido have been noted in male workers afflicted with manganism.

Due to the severe implications of manganese neurotoxicity, the Food and Nutrition Board (FNB) of the Institute of Medicine set very conservative tolerable upper intake levels (UL) for manganese; the ULs are listed in Table 1 according to age ⁵.

Note: The tolerable upper intake level (UL) is the highest level of daily intake of a specific nutrient likely to pose no risk of adverse health effects in almost all individuals of a specified age.

The adequate intake (AI) for manganese (2.3 mg/day for adult men and 1.8 mg/day for adult women) appears sufficient to prevent deficiency in most individuals. The daily intake of manganese most likely to promote optimum health is not known. Following the Linus Pauling Institute recommendation ⁶ to take a multivitamin/multimineral supplement containing 100% of the daily values (DV) of most nutrients will generally provide 2 mg/day of manganese in addition to that in foods. Because of the potential for toxicity and the lack of information regarding benefit, manganese supplementation beyond 100% of the DV (2 mg/day) is not recommended. There is presently no evidence that the consumption of a manganese-rich plant-based diet results in manganese toxicity.

Older adults (>50 years)

The requirement for manganese is not known to be higher for older adults. However, liver disease is more common in older adults and may increase the risk of manganese toxicity by decreasing the elimination of manganese from the body (see Manganese Toxicity). Manganese supplementation beyond 100% of the DV (2 mg/day) is not recommended.

How does Manganese work ?

Manganese is an essential nutrient involved in many chemical processes in the body, including processing of cholesterol, carbohydrates, and protein. It might also be involved in bone formation.

Manganese is essential for development, metabolism, and the antioxidant system. Nevertheless, excessive exposure or intake may lead to a condition known as manganism, a neurodegenerative disorder that causes dopaminergic neuronal death and symptoms similar to Parkinson’s disease ², ⁷. Manganese is a key ingredient in welding and industrial steel making, although occupational exposure is the biggest concern, communities located in close proximity to industrial sources can also be at risk of health impacts, primarily through the air ².

• Antioxidant function

Manganese superoxide dismutase (MnSOD) is the principal antioxidant enzyme in the mitochondria. Because mitochondria consume over 90% of the oxygen used by cells, they are especially vulnerable to oxidative stress. The superoxide radical is one of the reactive oxygen species produced in mitochondria during ATP synthesis. MnSOD catalyzes the conversion of superoxide radicals to hydrogen peroxide, which can be reduced to water by other antioxidant enzymes ⁸.

• Metabolism

A number of manganese-activated enzymes play important roles in the metabolism of carbohydrates, amino acids, and cholesterol ⁹. Pyruvate carboxylase, a manganese-containing enzyme, and phosphoenolpyruvate carboxykinase (PEPCK), a manganese-activated enzyme, are critical in gluconeogenesis — the production of glucose from non-carbohydrate precursors. Arginase, another manganese-containing enzyme, is required by the liver for the urea cycle, a process that detoxifies ammonia generated during amino acid metabolism ⁸. In the brain, the manganese-activated enzyme, glutamine synthetase, converts the amino acid glutamate to glutamine. Glutamate is an excitotoxic neurotransmitter and a precursor to an inhibitory neurotransmitter, γ-aminobutyric acid (GABA) ¹⁰, ¹¹.

• Bone development

Manganese deficiency results in abnormal skeletal development in a number of animal species. Manganese is the preferred cofactor of enzymes called glycosyltransferases; these enzymes are required for the synthesis of proteoglycans that are needed for the formation of healthy cartilage and bone ¹².

• Wound healing

Wound healing is a complex process that requires increased production of collagen. Manganese is required for the activation of prolidase, an enzyme that functions to provide the amino acid, proline, for collagen formation in human skin cells ¹³. A genetic disorder known as prolidase deficiency results in abnormal wound healing among other problems, and is characterized by abnormal manganese metabolism ¹². Glycosaminoglycan synthesis, which requires manganese-activated glycosyltransferases, may also play an important role in wound healing ¹⁴.

Nutrient interactions

• Iron

Although the specific mechanisms for manganese absorption and transport have not been determined, some evidence suggests that iron and manganese can share common absorption and transport pathways ¹⁵. Absorption of manganese from a meal decreases as the meal’s iron content increases ¹². Iron supplementation (60 mg/day for four months) was associated with decreased blood manganese levels and decreased MnSOD activity in white blood cells, indicating a reduction in manganese nutritional status ¹⁶. Additionally, an individual’s iron status can affect manganese bioavailability. Intestinal absorption of manganese is increased during iron deficiency, and increased iron stores (ferritin levels) are associated with decreased manganese absorption ¹⁷. Men generally absorb less manganese than women; this may be related to the fact that men usually have higher iron stores than women ¹⁸. Further, iron deficiency has been shown to increase the risk of manganese accumulation in the brain ¹⁹.

• Magnesium

Supplemental magnesium (200 mg/day) has been shown to slightly decrease manganese bioavailability in healthy adults, either by decreasing manganese absorption or by increasing its excretion ²⁰.

• Calcium

In one set of studies, supplemental calcium (500 mg/day) slightly decreased manganese bioavailability in healthy adults. As a source of calcium, milk had the least effect, while calcium carbonate and calcium phosphate had the greatest effect ²⁰. Several other studies have found minimal effects of supplemental calcium on manganese metabolism ²¹.

Sources

Manganese is a mineral that is found in several foods including nuts, legumes, seeds, tea, whole grains, and leafy green vegetables. It is considered an essential nutrient, because the body requires it to function properly. People use manganese as medicine.

 

The recommended daily amount (RDA) for manganese for adult male is 2.3 mg per day, for a woman is 1.8 mg, with 11 mg estimated as the tolerable upper limit (UL) for daily intake to avoid toxicity ²².

Manganese is likely safe for most adults when taken by mouth in amounts up to 11 mg per day. However, people who have trouble getting rid of manganese from the body, such as people with liver disease, may experience side effects when taking less than 11 mg per day.

Taking more than 11 mg per day by mouth is possibly unsafe for most adults.

The essential minimum intake is unknown since manganese deficiency is so rare ²³.

Food sources of Manganese

In the US, estimated average dietary manganese intakes range from 2.1 to 2.3 mg/day for men and 1.6 to 1.8 mg/day for women. People eating vegetarian diets and Western-type diets may have manganese intakes as high as 10.9 mg/day ⁵. Rich sources of manganese include whole grains, nuts, leafy vegetables, and teas. Foods high in phytic acid, such as beans, seeds, nuts, whole grains, and soy products, or foods high in oxalic acid, such as cabbage, spinach, and sweet potatoes, may slightly inhibit manganese absorption. Although teas are rich sources of manganese, the tannins present in tea may moderately reduce the absorption of manganese ²⁰. Intake of other minerals, including iron, calcium, and phosphorus, have been found to limit retention of manganese ⁵. The manganese content of some manganese-rich foods is listed in milligrams (mg) in Table 2. For more information on the nutrient content of foods, search the USDA food composition database ²⁴.

Table 2. Some Food Sources of Manganese

Food	Serving	Manganese (mg)
Pineapple, raw	½ cup, chunks	0.77
Pineapple juice	½ cup (4 fl. oz.)	0.63
Pecans	1 ounce (19 halves)	1.28
Almonds	1 ounce (23 whole kernels)	0.65
Peanuts	1 ounce	0.55
Instant oatmeal (prepared with water)	1 packet	0.99
Raisin bran cereal	1 cup	0.78-3.02
Brown rice, cooked	½ cup	1.07
Whole wheat bread	1 slice	0.60
Pinto beans, cooked	½ cup	0.39
Lima beans, cooked	½ cup	0.49
Navy beans, cooked	½ cup	0.48
Spinach, cooked	½ cup	0.84
Sweet potato, cooked	½ cup, mashed	0.44
Tea (green)	1 cup (8 ounces)	0.41-1.58
Tea (black)	1 cup (8 ounces)	0.18-0.77

 

• Breast milk and infant formulas

Infants are exposed to varying amounts of manganese depending on their source of nutrition. Manganese concentrations in breast milk, cow-based formula, and soy-based formula range from 3 to 10 μg/L, 30 to 50 μg/L, and 200 to 300 μg/L, respectively. However, bioavailability of manganese from breast milk is higher than from infant formulas, and manganese deficiencies in breast-fed infants or toxicities in formula-fed infants have not been reported ²⁵.

• Water

Manganese concentrations in drinking water range from 1 to 100 micrograms/liter (μg/L), but most sources contain less than 10 μg/L ²⁶. The US Environmental Protection Agency (EPA) recommends 0.05 mg (50 μg)/L as the maximum allowable manganese concentration in drinking water ²⁷.

• Supplements

Several forms of manganese are found in supplements, including manganese gluconate, manganese sulfate, manganese ascorbate, and amino acid chelates of manganese. Manganese is available as a stand-alone supplement or in combination products ²⁸. Relatively high levels of manganese ascorbate may be found in a bone/joint health product containing chondroitin sulfate and glucosamine hydrochloride (see Manganese Toxicity).

Manganese Deficiency

Overall, manganese deficiency is not common, and there is more concern for toxicity related to manganese overexposure (see manganese toxicity). Manganese deficiency has been observed in a number of animal species. Signs of manganese deficiency include impaired growth, impaired reproductive function, skeletal abnormalities, impaired glucose tolerance, and altered carbohydrate and lipid metabolism. In humans, demonstration of a manganese deficiency syndrome has been less clear ³, ¹². A child on long-term total parenteral nutrition (TPN) lacking manganese developed bone demineralization and impaired growth that were corrected by manganese supplementation ²⁹. Young men who were fed a low-manganese diet developed decreased serum cholesterol levels and a transient skin rash ³⁰. Blood calcium, phosphorus, and alkaline phosphatase levels were also elevated, which may indicate increased bone remodeling as a consequence of insufficient dietary manganese. Young women fed a manganese-poor diet developed mildly abnormal glucose tolerance in response to an intravenous (IV) infusion of glucose ²¹.

Manganese Overexposure and Toxicity

• Inhaled manganese

Manganese toxicity may result in multiple neurologic problems and is a well-recognized health hazard for people who inhale manganese dust, such as welders and smelters ³¹,⁵. Unlike ingested manganese, inhaled manganese is transported directly to the brain before it can be metabolized in the liver ³². The symptoms of manganese toxicity generally appear slowly over a period of months to years. In its worst form, manganese toxicity can result in a permanent neurological disorder with symptoms similar to those of Parkinson’s disease, including tremors, difficulty walking, and facial muscle spasms. This syndrome, often called manganism, is sometimes preceded by psychiatric symptoms, such as irritability, aggressiveness, and even hallucinations ³³, ³⁴. Additionally, environmental or occupational inhalation of manganese can cause an inflammatory response in the lungs ³⁵. Clinical symptoms of effects to the lung include cough, acute bronchitis, and decreased lung function ³⁶.

• Methylcyclopentadienyl manganese tricarbonyl (MMT)

MMT is a manganese-containing compound used in gasoline as an anti-knock additive. Although it has been used for this purpose in Canada for more than 20 years, uncertainty about adverse health effects from inhaled exhaust emissions kept the US EPA from approving its use in unleaded gasoline. In 1995, a US court decision made MMT available for widespread use in unleaded gasoline ³². A study in Montreal, where MMT had been used for more than 10 years, found airborne manganese levels to be similar to those in areas where MMT was not used ³⁷. A more recent Canadian study found higher concentrations of respirable manganese in an urban versus a rural area, but average concentrations in both areas were below the safe level set by the US EPA ³⁸. The impact of long-term exposure to low levels of MMT combustion products, however, has not been thoroughly evaluated and will require additional study ³⁹.

• Ingested manganese

Limited evidence suggests that high manganese intakes from drinking water may be associated with neurological symptoms similar to those of Parkinson’s disease. Severe neurological symptoms were reported in 25 people who drank water contaminated with manganese, and probably other contaminants, from dry cell batteries for two to three months ⁴⁰. Water manganese levels were found to be 14 mg/liter (mg/L) almost two months after symptoms began and may have already been declining. A study of older adults in Greece found a high prevalence of neurological symptoms in those exposed to water manganese levels of 1.8 to 2.3 mg/L ⁴¹, while a study in Germany found no evidence of increased neurological symptoms in people drinking water with manganese levels ranging from 0.3 to 2.2 mg/L compared to those drinking water containing less than 0.05 mg/L ⁴². Manganese in drinking water may be more bioavailable than manganese in food. However, none of the studies measured dietary manganese, so total manganese intake in these cases is unknown. In the US, the EPA recommends 0.05 mg/L as the maximum allowable manganese concentration in drinking water ⁴³.

Additionally, more recent studies have shown that children exposed to high levels of manganese through drinking water experience cognitive and behavioral deficits ⁴⁴. For instance, a cross-sectional study in 142, 10-year old children, who were exposed to a mean manganese water concentration of 0.8 mg/L, found that children exposed to higher manganese levels had significantly lower scores on three tests of intellectual function ⁴⁵. Another study associated high levels of manganese in tap water with hyperactive behavioral disorders in children ⁴⁶. These and other recent reports have raised concern over the neurobehavioral effects of manganese exposure in children ⁴⁴.

A single case of manganese toxicity was reported in a person who took large amounts of mineral supplements for years ⁴⁷, while another case was reported as a result of a person taking a Chinese herbal supplement ³³. Manganese toxicity resulting from foods alone has not been reported in humans, even though certain vegetarian diets could provide up to 20 mg/day of manganese ⁵, ²⁶.

• Intravenous manganese

Manganese neurotoxicity has been observed in individuals receiving total parenteral nutrition, both as a result of excessive manganese in the solution and as an incidental contaminant ⁴⁸. Neonates are especially vulnerable to manganese-related neurotoxicity ⁴⁹. Infants receiving manganese-containing TPN can be exposed to manganese concentrations about 100-fold higher than breast-fed infants ²⁵. Because of potential toxicities, some argue against including manganese in parenteral nutrition ⁵⁰.

• Individuals with increased susceptibility to manganese toxicity

Chronic liver disease: Manganese is eliminated from the body mainly in bile. Thus, impaired liver function may lead to decreased manganese excretion. Manganese accumulation in individuals with cirrhosis or liver failure may contribute to neurological problems and Parkinson’s disease-like symptoms ³¹, ²⁸.

Newborns: The newborn brain may be more susceptible to manganese toxicity due to a greater expression of receptors for the manganese transport protein (transferrin) in developing nerve cells and the immaturity of the liver’s bile elimination system ⁵.

Children: Compared to adults, infants and children have higher intestinal absorption of manganese, as well as lower biliary excretion of manganese ⁴⁴. Thus, children are especially susceptible to any negative, neurotoxic effects of manganese. Indeed, several recent studies in school-aged children have reported deleterious cognitive and behavioral effects following excessive manganese exposure ⁴⁵, ⁴⁶, ⁵¹.

Iron-deficient populations: Iron deficiency has been shown to increase the risk of manganese accumulation in the brain ¹⁹.

References

1. Linus Pauling Institute, Oregon State University. http://lpi.oregonstate.edu/mic/minerals/manganese
2. US Environmental Protection Agency. Studying Manganese Exposure in Eastern Ohio. https://www.epa.gov/healthresearch/studying-manganese-exposure-eastern-ohio
3. Nielsen FH. Ultratrace minerals. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams & Wilkins; 1999:283-303.
4. Food and Nutrition Board, Institute of Medicine. Manganese. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press; 2001:394-419. (National Academy Press
5. Food and Nutrition Board, Institute of Medicine. Manganese. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press; 2001:394-419. https://www.nap.edu/read/10026/chapter/1
6. http://lpi.oregonstate.edu/mic/minerals/manganese#safety
7. Emsley, John (2001). “Manganese”. Nature’s Building Blocks: An A-Z Guide to the Elements. Oxford, UK: Oxford University Press. pp. 249–253.
8. Leach RM, Harris ED. Manganese. In: O’Dell BL, Sunde RA, eds. Handbook of nutritionally essential minerals. New York: Marcel Dekker, Inc; 1997:335-355.
9. Food and Nutrition Board, Institute of Medicine. Manganese. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press; 2001:394-419.
10. Wedler FC. Biochemical and nutritional role of manganese: an overview. In: Klimis-Tavantzis DJ (ed). Manganese in health and disease. Boca Raton: CRC Press, Inc.; 1994:1-37.
11. Albrecht J, Sonnewald U, Waagepetersen HS, Schousboe A. Glutamine in the central nervous system: function and dysfunction. Front Biosci. 2007;12:332-343. https://www.ncbi.nlm.nih.gov/pubmed/17127302
12. Keen CL, Zidenberg-Cherr S. Manganese. In: Ziegler EE, Filer LJ, eds. Present Knowledge in Nutrition. 7th ed. Washington D.C.: ILSI Press; 1996:334-343.
13. Muszynska A, Palka J, Gorodkiewicz E. The mechanism of daunorubicin-induced inhibition of prolidase activity in human skin fibroblasts and its implication to impaired collagen biosynthesis. Exp Toxicol Pathol. 2000;52(2):149-155. https://www.ncbi.nlm.nih.gov/pubmed/10965990
14. Shetlar MR, Shetlar CL. The role of manganese in wound healing. In: Klimis-Tavantzis DL, ed. Manganese in health and disease. Boca Raton: CRC Press, Inc.; 1994:145-157.
15. Fitsanakis VA, Zhang N, Garcia S, Aschner M. Manganese (Mn) and Iron (Fe): Interdependency of Transport and Regulation. Neurotox Res. 2009. https://www.ncbi.nlm.nih.gov/pubmed/19921534
16. Davis CD, Greger JL. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am J Clin Nutr. 1992;55(3):747-752. https://www.ncbi.nlm.nih.gov/pubmed/1550052
17. Finley JW. Manganese absorption and retention by young women is associated with serum ferritin concentration. Am J Clin Nutr. 1999;70(1):37-43. https://www.ncbi.nlm.nih.gov/pubmed/10393136
18. Finley JW, Johnson PE, Johnson LK. Sex affects manganese absorption and retention by humans from a diet adequate in manganese. Am J Clin Nutr. 1994;60(6):949-955. https://www.ncbi.nlm.nih.gov/pubmed/7985639
19. Aschner M, Dorman DC. Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev. 2006;25(3):147-154. https://www.ncbi.nlm.nih.gov/pubmed/17192121
20. Kies C. Bioavailability of manganese. In: Klimis-Tavantzis DL, ed. Manganese in health and disease. Boca Raton: CRC Press, Inc; 1994:39-58.
21. Johnson PE, Lykken GI. Manganese and calcium absorption and balance in young women fed diets with varying amounts of manganese and calcium. J Trace Elem Exp Med. 1991;4:19-35.
22. Harvard University. Harvard Health Publications. Listing of vitamins, published: June, 2009. http://www.health.harvard.edu/staying-healthy/listing_of_vitamins
23. Micronutrient Information Center. Oregon State University Linus Pauling Institute.
24. US Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 22. 2009. https://ndb.nal.usda.gov/ndb/
25. Aschner JL, Aschner M. Nutritional aspects of manganese homeostasis. Mol Aspects Med. 2005;26(4-5):353-362. https://www.ncbi.nlm.nih.gov/pubmed/16099026
26. Keen CL, Zidenberg-Cherr S. Manganese toxicity in humans and experimental animals. In: Klimis-Tavantzis DL, ed. Manganese in health and disease. Boca Raton: CRC Press, Inc; 1994:193-205.
27. EPA Office of Water. Current Drinking Water Standards. Environmental Protection Agency. https://safewater.zendesk.com/hc/en-us/categories/201454937
28. Hendler SS, Rorvik DR, eds. PDR for Nutritional Supplements. Montvale: Medical Economics Company, Inc; 2001.
29. Norose N, Terai M, Norose K. Manganese deficiency in a child with very short bowel syndrome receiving long-term parenteral nutrition. J Trace Elem Exp Med. 1992;5:100-101 (abstract).
30. Friedman BJ, Freeland-Graves JH, Bales CW, et al. Manganese balance and clinical observations in young men fed a manganese-deficient diet. J Nutr. 1987;117(1):133-143. https://www.ncbi.nlm.nih.gov/pubmed/3819860
31. Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicology. 1999;20(2-3):213-223. https://www.ncbi.nlm.nih.gov/pubmed/10385885
32. Davis JM. Methylcyclopentadienyl manganese tricarbonyl: health risk uncertainties and research directions. Environ Health Perspect. 1998;106 Suppl 1:191-201. https://www.ncbi.nlm.nih.gov/pubmed/9539013
33. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology. 1999;20(2-3):227-238. https://www.ncbi.nlm.nih.gov/pubmed/10385886
34. Aschner M, Aschner JL. Manganese neurotoxicity: cellular effects and blood-brain barrier transport. Neurosci Biobehav Rev. 1991;15(3):333-340. https://www.ncbi.nlm.nih.gov/pubmed/1956602
35. Han J, Lee JS, Choi D, et al. Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: implication in manganese-induced pulmonary inflammation. Toxicol Appl Pharmacol. 2009;235(3):261-267. https://www.ncbi.nlm.nih.gov/pubmed/19263519
36. Roels H, Lauwerys R, Buchet JP, et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med. 1987;11(3):307-327. https://www.ncbi.nlm.nih.gov/pubmed/3578289
37. Zayed J, Thibault C, Gareau L, Kennedy G. Airborne manganese particulates and methylcyclopentadienyl manganese tricarbonyl (MMT) at selected outdoor sites in Montreal. Neurotoxicology. 1999;20(2-3):151-157. https://www.ncbi.nlm.nih.gov/pubmed/10385879
38. Bolte S, Normandin L, Kennedy G, Zayed J. Human exposure to respirable manganese in outdoor and indoor air in urban and rural areas. J Toxicol Environ Health A. 2004;67(6):459-467. https://www.ncbi.nlm.nih.gov/pubmed/15000130
39. Aschner M. Manganese: brain transport and emerging research needs. Environ Health Perspect. 2000;108 Suppl 3:429-432. https://www.ncbi.nlm.nih.gov/pubmed/10852840
40. Kawamura R. Intoxication by manganese in well water. Kisasato Archives of Experimental Medicine. 1941;18:145-169.
41. Kondakis XG, Makris N, Leotsinidis M, Prinou M, Papapetropoulos T. Possible health effects of high manganese concentration in drinking water. Arch Environ Health. 1989;44(3):175-178. https://www.ncbi.nlm.nih.gov/pubmed/2751354
42. Vieregge P, Heinzow B, Korf G, Teichert HM, Schleifenbaum P, Mosinger HU. Long term exposure to manganese in rural well water has no neurological effects. Can J Neurol Sci. 1995;22(4):286-289. https://www.ncbi.nlm.nih.gov/pubmed/8599771
43. EPA Office of Water. Current Drinking Water Standards. Environmental Protection Agency. https://www.nap.edu/read/10026/chapter/1
44. Ljung K, Vahter M. Time to re-evaluate the guideline value for manganese in drinking water? Environ Health Perspect. 2007;115(11):1533-1538. https://www.ncbi.nlm.nih.gov/pubmed/18007980
45. Wasserman GA, Liu X, Parvez F, et al. Water manganese exposure and children’s intellectual function in Araihazar, Bangladesh. Environ Health Perspect. 2006;114(1):124-129. https://www.ncbi.nlm.nih.gov/pubmed/16393669
46. Bouchard M, Laforest F, Vandelac L, Bellinger D, Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect. 2007;115(1):122-127. https://www.ncbi.nlm.nih.gov/pubmed/17366831
47. Keen C, Zidenberg-Cherr S. Manganese toxicity in humans and experimental animals. In: Klimis-Tavantzis D (ed). Manganese in health and disease. Boca Raton: CRC Press, Inc.; 1994.
48. Dobson AW, Erikson KM, Aschner M. Manganese neurotoxicity. Ann NY Acad Sci. 2004;1012:115-128. https://www.ncbi.nlm.nih.gov/pubmed/15105259
49. Erikson KM, Thompson K, Aschner J, Aschner M. Manganese neurotoxicity: a focus on the neonate. Pharmacol Ther. 2007;113(2):369-377. https://www.ncbi.nlm.nih.gov/pubmed/17084903
50. Hardy IJ, Gillanders L, Hardy G. Is manganese an essential supplement for parenteral nutrition? Curr Opin Clin Nutr Metab Care. 2008;11(3):289-296. https://www.ncbi.nlm.nih.gov/pubmed/18403926
51. Wright RO, Amarasiriwardena C, Woolf AD, Jim R, Bellinger DC. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006;27(2):210-216. https://www.ncbi.nlm.nih.gov/pubmed/16310252